Clearmind Medicine Inc.

This early-stage study aims to find a safe and tolerable dose of an investigational drug called CMND-100. It will test the drug first in healthy volunteers and then in people with moderate to severe alcohol use disorder. The study will also gather preliminary information on wheth…